XIIlab
Key metrics
Earnings
| Revenue, Q3 2026 | ₩5.6bn |
|---|---|
| Revenue QoQ | +179.3% |
| Revenue YoY | +46.5% |
| Operating income, Q3 2026 | -₩1.3bn |
| Operating income QoQ | +51.7% |
| Operating income YoY | -98.4% |
Share buybacks
| Buyback decided, last 3 months | ₩0 |
|---|---|
| Buyback decided, last 3 months, % of shares | 0.0% |
| Shares acquired, last 3 months | ₩0 |
| Shares acquired, last 3 months, % of shares | 0.0% |
| Treasury shares cancelled, last 3 months | ₩0 |
| Treasury shares cancelled (number), last 3 months | 0 shares |
| Treasury shares cancelled, last 3 months, % of shares | 0.0% |
| Buyback decided, last 12 months | ₩0 |
| Buyback decided, last 12 months, % of shares | 0.0% |
| Shares acquired, last 12 months | ₩0 |
| Shares acquired, last 12 months, % of shares | 0.0% |
| Treasury shares cancelled, last 12 months | ₩0 |
| Treasury shares cancelled (number), last 12 months | 0 shares |
| Treasury shares cancelled, last 12 months, % of shares | 0.0% |
Potential dilution
| CB/BW/EB issued, last 12 months | ₩10.0bn |
|---|---|
| Rights offering new shares, last 12 months | 0 shares |
| Potential new shares, last 12 months | 1,233,654 shares |
| Potential new shares, % of shares | 13.1% |
| Conversion price adjustments, last 12 months | 0 |
Supply contracts
| Supply contracts, last 12 months | ₩363.5bn |
|---|---|
| Supply contracts vs prior-year revenue | 3538.4% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Disclosure activity
| DART filings, last 3 months | 11 |
|---|---|
| DART filings, previous 3 months | 13 |
Insider transactions
| Open-market buys, last 12 months (shares) | 0 shares |
|---|---|
| Open-market buys, last 12 months (amount) | ₩0 |
| Open-market sells, last 12 months (shares) | 0 shares |
| Open-market sells, last 12 months (amount) | ₩0 |
| Net open-market buying, last 12 months (shares) | 0 shares |
| Insiders who bought, last 12 months | 0 |
Insider transactions (last 12 months)
No insider transactions in the last 12 months.
Annual financials
| Year | Revenue | Operating income |
|---|---|---|
| 2025 | ₩10.3bn | -₩3.2bn |
| 2024 | ₩9.1bn | -₩5.3bn |
| 2023 | ₩3.7bn | -₩6.9bn |
Filing timeline
-
XIIlab to issue ₩10.0bn zero-coupon convertible bonds due 2031
XIIlab filed for a ₩10.0bn convertible bond issue maturing Nov 16, 2031, with a 0.0% coupon. The conversion price is ₩8,106, which could result in 1,233,654 shares, equal to 11.6% of total shares.
-
XIIlab signs ₩1.8bn NVIDIA DGX system supply contract
XIIlab signed an NVIDIA DGX system supply contract worth ₩1.8bn with Naraspace Technology. The contract period runs from Oct 27, 2026 to Jun 1, 2030. The filing reports the contract as 17.0% of revenue.
-
XIIlab signs ₩1.9bn AI infrastructure contract with Super Solution
XIIlab signed a ₩1.9bn AI infrastructure supply contract with Super Solution Co., Ltd. The contract period runs from Oct 16, 2026 to Jul 31, 2027, and the amount is 18.6% of revenue as reported.
-
XIIlab signs ₩3.1bn NVIDIA AI supply contract with Algorix
XIIlab signed a ₩3.1bn supply contract with Algorix Corporation for NVIDIA DGX Rubin NVL8 and NVIDIA AI Enterprise, running from Oct 8, 2026 to Jul 31, 2027. The filing states the contract amount as 29.7% of revenue.
-
XIIlab signs ₩2.2bn AI infrastructure supply contract with Taejin TNS
XIIlab filed a supply contract for the AI infrastructure construction project with counterparty Taejin TNS, worth ₩2.2bn. The contract period runs from Oct 2, 2026 to Dec 31, 2027, and the filing reports it as 21.3% of revenue.